-
WuXi Biologics launches commercial manufacturing through biologics center expansion — 4 insights
Chinese biologics technology company WuXi Biologics is expanding its conjugation solution center to include commercial manufacturing later this year. -
AlloSource joins Advanced Regenerative Manufacturing Institute — 3 insights
AlloSource partnered with Manufacturing USA in a new public-private initiative, the Advanced Regenerative Manufacturing Institute. -
Private investment firm invests in Royal Biologics — 4 insights
Granite Creek Capital Partners, a private investment firm in Chicago, invested in regenerative medicine company Royal Biologics. -
Ortho RTi unveils new CEO — 4 quick insights
Orthopedic and sports medicine technology company Ortho Regenerative Technologies unveiled Claude LeDuc as its new president and CEO, according to Biospace. -
Minnesota seeks to expand stem cell research through state initiative — 4 insights
Regenerative Medicine Minnesota is a bipartisan effort to improve research, technology, education and patient access to regenerative medicine-based treatments. -
Stem cell controversies — Where we are in 2019
Regenerative medicine has life-changing potential, but illegal actors are spurring a rash of regulatory activities. -
4 key updates in biologics for spine
Here are four key updates in about spinal biologics companies and advancements. -
California stem cell clinic scrutinized — 5 insights
East Bay Health and Wellness Center, which offers chiropractic and wellness services in Walnut Creek, Calif., caught the ire of local CBS affiliate KPIX 5 for the unconventional way it markets unproven stem cell treatments. -
Biomatrix develops minimally invasive biomaterial to treat intervertebral disc degeneration
NC Biomatrix BV is producing a biomaterial that will assist the treatment of intervertebral disc degeneration in a minimally invasive way, reports Innovation Origins. -
Dr. Robert LaPrade on the biggest thing to hit sports medicine since the arthroscope
Robert LaPrade, MD, PhD, a complex knee and sports medicine surgeon, joined Golden Valley, Minn.-based Twin Cities Orthopedics June 3. -
Biomaterials startup raises $500K for scaffolds to treat spinal cord injuries
Ottawa, Canada-based biomaterials startup Spiderwort closed a $500,000 oversubscribed friends and family funding round, reports BetaKit. -
Ossio wins Frost & Sullivan award for bone regeneration technology — 4 insights
Orthopedic fixation company, Ossio, won the 2019 Frost & Sullivan North America New Product Innovation Award for its bone regeneration device, Ossiofiber. -
InGeneron raises $43M financing for regenerative cell shoulder program
Regenerative medicine and cell therapy company InGeneron extended its Series D financing by up to $23 million, totaling $43 million, to be invested in the company. -
Konica Minolta Healthcare partners with EmCyte in biologics workshop
Konica Minolta Healthcare is hosting an autologous biologics workshop in collaboration with EmCyte to support education for ultrasound-guided musculoskeletal inventions. -
Bioventus collaborates with MTF Biologics in tissue product for knee osteoarthritis
Bioventus has partnered with MTF Biologics to co-develop a placental tissue product for the treatment of painful musculoskeletal conditions, focusing initially on knee osteoarthritis. -
R3 Stem Cell responds to FDA's safety concerns — 3 insights
Scottsdale, Ariz.-based R3 Stem Cell responded to an FDA letter that raised safety and legality concerns over R3's stem cell offerings. -
Judge grants FDA permission to regulate stem cell practice — 3 insights
A federal judge granted the FDA authority to regulate treatments from U.S. Stem Cell Clinic and U.S. Stem Inc., NBC News reports. -
Dr. Andrew Cappuccino to treat spine patients at new stem cell therapy center
Niagara Falls (N.Y.) Memorial Medical Center and Andrew Cappuccino, MD, of Buffalo (N.Y.) Spine Surgery are opening a stem cell therapy center, reports WNY Papers.com. -
Spinal fusion at physician-owned hospitals vs. non-POHs: 4 key findings
A new study published in The Spine Journal examines outcomes from posterior lumbar fusions at a physician-owned hospital compared with a non-physician-owned hospital. -
Emory physician leading osteoarthritis stem cell study
Atlanta-based Emory Orthopedics & Spine Center's Ken Mautner, MD, is studying how three different stem cell therapies treat osteoarthritis, local news affiliate Fox 5 reports.
Page 18 of 34